The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson's disease (PD) and other neurodegenerative synucleinopathies. This process is selectively enhanced by copper in vitro and the interaction is proposed to play a potential role in vivo. Presently, the identity of the Cu(I) binding sites in AS and their relative affinities are under debate. In this work we have addressed unresolved details related to the structural binding specificity and affinity of Cu(I) to full-length AS. We demonstrated conclusively that: (i) the binding preferences of Cu(I) for the Met-binding sites at the N- (Kd = 20 μM) and C-terminus (Kd = 270 μM) of AS are widely different: (ii) the imidazole ring of His-50 acts as an effective anc...
Amyloid aggregation of a-synuclein (AS) has been linked to the pathological effects associated with ...
The identity of the Cu(i) binding ligands at Met-X3-Met site of AcαS and its role into the affinity ...
The aggregation of α -synuclein (AS) is characteristic of Parkinson’s disease and other neurodegener...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson's disease (P...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson's disease (P...
The amyloid aggregation of alpha-synuclein (AS) has been linked to the pathological effects associat...
Abstract: The aggregation of R-synuclein (AS) is selectively enhanced by copper in vitro, and the in...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson's disease (P...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson’s disease (P...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson’s disease (P...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson’s disease (P...
Amyloid aggregation of a-synuclein (AS) has been linked to the pathological effects associated with ...
The aggregation of alpha-synuclein (alpha S) is a critical step in the etiology of Parkinson's disea...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson's disease (P...
Alpha-synuclein (AS) aggregation is associated with neurodegeneration in Parkinson'sdisease (PD). At...
Amyloid aggregation of a-synuclein (AS) has been linked to the pathological effects associated with ...
The identity of the Cu(i) binding ligands at Met-X3-Met site of AcαS and its role into the affinity ...
The aggregation of α -synuclein (AS) is characteristic of Parkinson’s disease and other neurodegener...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson's disease (P...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson's disease (P...
The amyloid aggregation of alpha-synuclein (AS) has been linked to the pathological effects associat...
Abstract: The aggregation of R-synuclein (AS) is selectively enhanced by copper in vitro, and the in...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson's disease (P...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson’s disease (P...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson’s disease (P...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson’s disease (P...
Amyloid aggregation of a-synuclein (AS) has been linked to the pathological effects associated with ...
The aggregation of alpha-synuclein (alpha S) is a critical step in the etiology of Parkinson's disea...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson's disease (P...
Alpha-synuclein (AS) aggregation is associated with neurodegeneration in Parkinson'sdisease (PD). At...
Amyloid aggregation of a-synuclein (AS) has been linked to the pathological effects associated with ...
The identity of the Cu(i) binding ligands at Met-X3-Met site of AcαS and its role into the affinity ...
The aggregation of α -synuclein (AS) is characteristic of Parkinson’s disease and other neurodegener...